Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Experience with a metered-dose inhaler with a spacer in the pediatric emergency department.
Benton G, Thomas RC, Nickerson BG, McQuitty JC, Okikawa J. Benton G, et al. Among authors: okikawa j. Am J Dis Child. 1989 Jun;143(6):678-81. doi: 10.1001/archpedi.1989.02150180056020. Am J Dis Child. 1989. PMID: 2729211
Comparison of in vitro and in vivo efficiencies of a novel unit-dose liquid aerosol generator and a pressurized metered dose inhaler.
Farr SJ, Warren SJ, Lloyd P, Okikawa JK, Schuster JA, Rowe AM, Rubsamen RM, Taylor G. Farr SJ, et al. Among authors: okikawa jk. Int J Pharm. 2000 Mar 30;198(1):63-70. doi: 10.1016/s0378-5173(99)00452-4. Int J Pharm. 2000. PMID: 10722951 Clinical Trial.
Effect of gender and device mouthpiece shape on bolus insulin aerosol delivery using the AERx pulmonary delivery system.
Boyd B, Noymer P, Liu K, Okikawa J, Hasegawa D, Warren S, Taylor G, Ferguson E, Schuster J, Farr S, Gonda I. Boyd B, et al. Among authors: okikawa j. Pharm Res. 2004 Oct;21(10):1776-82. doi: 10.1023/ Pharm Res. 2004. PMID: 15553222
Pulmonary insulin administration using the AERx system: physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects.
Farr SJ, McElduff A, Mather LE, Okikawa J, Ward ME, Gonda I, Licko V, Rubsamen RM. Farr SJ, et al. Among authors: okikawa j. Diabetes Technol Ther. 2000 Summer;2(2):185-97. doi: 10.1089/15209150050025131. Diabetes Technol Ther. 2000. PMID: 11469258
Safety and pharmacokinetics of inhaled morphine delivered using the AERx system in patients with moderate-to-severe asthma.
Otulana B, Okikawa J, Linn L, Morishige R, Thipphawong J. Otulana B, et al. Among authors: okikawa j. Int J Clin Pharmacol Ther. 2004 Aug;42(8):456-62. doi: 10.5414/cpp42456. Int J Clin Pharmacol Ther. 2004. PMID: 15366326 Clinical Trial.
Evaluation of the AERx pulmonary delivery system for systemic delivery of a poorly soluble selective D-1 agonist, ABT-431.
Okumu FW, Lee RY, Blanchard JD, Queirolo A, Woods CM, Lloyd PM, Okikawa J, Gonda I, Farr SJ, Rubsamen R, Adjei AL, Bertz RJ. Okumu FW, et al. Among authors: okikawa j. Pharm Res. 2002 Jul;19(7):1009-12. doi: 10.1023/a:1016559707084. Pharm Res. 2002. PMID: 12180532 Clinical Trial.
Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis.
Geller D, Thipphawong J, Otulana B, Caplan D, Ericson D, Milgram L, Okikawa J, Quan J, Bowman CM. Geller D, et al. Among authors: okikawa j. J Aerosol Med. 2003 Summer;16(2):175-82. doi: 10.1089/089426803321919933. J Aerosol Med. 2003. PMID: 12823911
Compliance with inhaled insulin treatment using the AERx iDMS Insulin Diabetes Management System.
Cramer JA, Okikawa J, Bellaire S, Clauson P. Cramer JA, et al. Among authors: okikawa j. Diabetes Technol Ther. 2004 Dec;6(6):800-7. doi: 10.1089/dia.2004.6.800. Diabetes Technol Ther. 2004. PMID: 15684632 Clinical Trial.
Pulmonary insulin administration using the AERx insulin diabetes system.
Thipphawong J, Otulana B, Clauson P, Okikawa J, Farr SJ. Thipphawong J, et al. Among authors: okikawa j. Diabetes Technol Ther. 2002;4(4):499-504. doi: 10.1089/152091502760306580. Diabetes Technol Ther. 2002. PMID: 12396744 No abstract available.
Intrapulmonary and intravenous administrations of dihydroergotamine mesylate have similar cardiovascular effects in the conscious dog.
Shrewsbury SB, Stonerook M, Okikawa JK. Shrewsbury SB, et al. Among authors: okikawa jk. Br J Pharmacol. 2008 Jul;154(6):1254-65. doi: 10.1038/bjp.2008.187. Epub 2008 May 26. Br J Pharmacol. 2008. PMID: 18500365 Free PMC article.
13 results
Jump to page